Aoyuan Healthy Life Group Company Limited
HKEX:3662.HK
0.47 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,563.01 | 1,629.751 | 1,941.747 | 1,408.089 | 900.8 | 618.835 | 435.977 | 265.44 | 179.463 |
| Cost of Revenue
| 1,163.389 | 1,232.536 | 1,472.172 | 926.711 | 563.746 | 410.082 | 287.519 | 182.865 | 129.58 |
| Gross Profit
| 399.621 | 397.215 | 469.575 | 481.378 | 337.054 | 208.753 | 148.458 | 82.575 | 49.883 |
| Gross Profit Ratio
| 0.256 | 0.244 | 0.242 | 0.342 | 0.374 | 0.337 | 0.341 | 0.311 | 0.278 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 136.161 | 173.745 | 188.816 | 149.715 | 141.894 | 104.558 | 17.532 | 8.016 | 2.907 |
| Selling & Marketing Expenses
| 1.258 | 1.296 | 5.757 | 2.347 | 2.47 | 1.331 | 0.321 | 0.22 | 0.344 |
| SG&A
| 137.419 | 175.041 | 194.573 | 152.062 | 144.364 | 105.889 | 17.853 | 8.236 | 3.251 |
| Other Expenses
| -0.108 | -28.329 | -22.462 | -10.705 | 5.844 | 0.835 | 0.375 | 0.754 | 0.093 |
| Operating Expenses
| 115.273 | 146.712 | 172.111 | 141.357 | 144.364 | 105.889 | 47.738 | 23.382 | 12.146 |
| Operating Income
| 300.718 | 212.121 | 129.11 | 348.097 | 219.918 | 102.864 | 100.72 | 59.193 | 37.737 |
| Operating Income Ratio
| 0.192 | 0.13 | 0.066 | 0.247 | 0.244 | 0.166 | 0.231 | 0.223 | 0.21 |
| Total Other Income Expenses Net
| -89.77 | -50.905 | -303.396 | -14.426 | -1.305 | 5.631 | -0.314 | 0.2 | -0.219 |
| Income Before Tax
| 194.578 | 199.598 | -174.286 | 325.587 | 218.613 | 108.495 | 100.406 | 59.393 | 37.518 |
| Income Before Tax Ratio
| 0.124 | 0.122 | -0.09 | 0.231 | 0.243 | 0.175 | 0.23 | 0.224 | 0.209 |
| Income Tax Expense
| 45.369 | 36.434 | 23 | 72.598 | 55.503 | 30.24 | 30.474 | 18.365 | 10.603 |
| Net Income
| 157.137 | 160.407 | -197.286 | 251.114 | 162.478 | 78.144 | 69.75 | 41.005 | 26.915 |
| Net Income Ratio
| 0.101 | 0.098 | -0.102 | 0.178 | 0.18 | 0.126 | 0.16 | 0.154 | 0.15 |
| EPS
| 0.22 | 0.22 | -0.27 | 0.34 | 0.24 | 0.11 | 0.1 | 0.059 | 0.039 |
| EPS Diluted
| 0.22 | 0.22 | -0.27 | 0.34 | 0.24 | 0.11 | 0.1 | 0.059 | 0.039 |
| EBITDA
| 326.846 | 245.27 | -108.961 | 368.71 | 233.083 | 121.207 | 106.61 | 59.954 | 38.559 |
| EBITDA Ratio
| 0.209 | 0.188 | 0.084 | 0.266 | 0.258 | 0.183 | 0.238 | 0.234 | 0.219 |